Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2021

Rhea-AI Summary

Erytech Pharma has released its monthly report on total voting rights and shares as of November 30, 2021. The total number of shares composing the share capital reached 27,940,121, with 29,439,907 gross voting rights and 29,437,407 net voting rights. This information is essential for shareholders and regulatory compliance under French financial regulations, specifically Article 223-16. The company's shares are listed on both Euronext Paris and the Nasdaq Global Select Market.

Positive

• Total shares increased to 27,940,121, indicating potential shareholder confidence.
• Gross voting rights reached 29,439,907, a positive sign for governance.

Negative

• None.

               

Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2021.

Article 223-16 of general regulation of French Autorité des Marchés Financiers
Lyon – France

---

Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (Symbol : ERYP)
Website : www.erytech.com

Date	Total of shares composing the share capital	Total of brut (1) voting rights	Total of net (2) voting rights
December 31, 2020	20 057 562	21 592 598	21 590 098
January 31, 2021	20 395 482	21 930 518	21 928 018
February 28, 2021	21 139 668	22 668 705	22 666 205
March 31, 2021	21 619 894	23 149 446	23 146 946
April 30, 2021	21 646 489	23 176 061	23 173 561
May 31, 2021	26 048 225	27 569 797	27 567 297
June 30, 2021	26 412 389	27 934 088	27 931 588
July 30, 2021	27 320 457	28 844 656	28 842 156
August 31, 2021	27 729 047	29 250 818	29 248 318
September 30, 2021	27 923 522	29 423 496	29 420 996
October 30, 2021	27 923 522	29 423 308	29 420 808
November 30, 2021	27 940 121	29 439 907	29 437 407

⁽¹⁾   Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
⁽²⁾   Without treasury shares.

Attachment

• CP_Déclaration Droits de Vote 30 11 2021 vENG

FAQ

What are the total voting rights for ERPY as of November 30, 2021?

As of November 30, 2021, the total gross voting rights for ERPY are 29,439,907.

How many shares compose the share capital for Erytech Pharma as of November 30, 2021?

The total number of shares composing the share capital for Erytech Pharma as of November 30, 2021, is 27,940,121.

What is the significance of the voting rights report for Erytech Pharma?

The voting rights report is crucial for regulatory compliance and provides shareholders essential information regarding their governance rights.

Where is Erytech Pharma listed?

Erytech Pharma is listed on Euronext Paris and the Nasdaq Global Select Market under the symbol ERPY.